Galmed Pharmaceuticals (FRA:GPH) Other Long Term Assets : €0.25 Mil (As of Dec. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Galmed Pharmaceuticals Other Long Term Assets?

Galmed Pharmaceuticals's other long-term assets for the quarter that ended in Dec. 2024 was €0.25 Mil.

Galmed Pharmaceuticals's quarterly other long-term assets increased from Jun. 2024 (€-0.00 Mil) to Sep. 2024 (€0.00 Mil) and increased from Sep. 2024 (€0.00 Mil) to Dec. 2024 (€0.25 Mil).

Galmed Pharmaceuticals's annual other long-term assets declined from Dec. 2022 (€0.00 Mil) to Dec. 2023 (€-0.00 Mil) but then increased from Dec. 2023 (€-0.00 Mil) to Dec. 2024 (€0.25 Mil).

Galmed Pharmaceuticals Other Long Term Assets Historical Data

The historical data trend for Galmed Pharmaceuticals's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Galmed Pharmaceuticals Other Long Term Assets Chart

Galmed Pharmaceuticals Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Other Long Term Assets

Get a 7-Day Free Trial

0.25

Galmed Pharmaceuticals Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Other Long Term Assets	Get a 7-Day Free Trial															-	-	-	-	0.25

Galmed Pharmaceuticals Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

Galmed Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Galmed Pharmaceuticals Ltd (FRA:GPH) » Definitions » Other Long Term Assets

Comparable Companies

Traded in Other Exchanges

GLMD:USA

Address

16 Abba Hillel Road, Ramat Gan, ISR, 5250608

Website

https://www.galmedpharma.com

Galmed Pharmaceuticals Ltd is a biopharmaceutical company. It focuses on the development of Aramchol. exclusively on developing Aramchol for the treatment of liver disease and were previously developing Aramchol for primary sclerosing cholangitis, PSC, and exploring the feasibility of developing Aramchol for other fibro-inflammatory indications outside of NASH and fibrosis. The company is currently seeking to advance the development of Aramchol for oncological indications outside of NASH and fibrosis.

Galmed Pharmaceuticals Headlines

No Headlines